JACIE pursues the same goals as the Foundation for the Accreditation of Cell Therapy (FACT), the accreditation program for hematopoietic stem cell transplantation (HSCT) activities in North America: both aim at promoting excellence (1), harmonization and improving clinical results. FACT – JACIE standards (the fi fth version is currently being prepared) establish criteria for a comprehensive quality management program that covers the three critical domains in HSCT: clinical, collection and processing, and their interactions with ancillary activities. The reasons for JACIE and FACT include the complexity of the therapeutic procedure, the production of cell-based medicinal products by academic facilities rather than by pharmaceutical companies.
Chabannon C., Pamphilon D., Vermylen C., Gratwohl A., Niederwieser D., McGrath E., et al. (2011). JACIE celebrates its 10-year anniversary with the demonstration of improved clinical outcome. CYTOTHERAPY, 13(6), 765-766 [10.3109/14653249.2011.556110].
JACIE celebrates its 10-year anniversary with the demonstration of improved clinical outcome
Lanza F.Membro del Collaboration Group
;
2011
Abstract
JACIE pursues the same goals as the Foundation for the Accreditation of Cell Therapy (FACT), the accreditation program for hematopoietic stem cell transplantation (HSCT) activities in North America: both aim at promoting excellence (1), harmonization and improving clinical results. FACT – JACIE standards (the fi fth version is currently being prepared) establish criteria for a comprehensive quality management program that covers the three critical domains in HSCT: clinical, collection and processing, and their interactions with ancillary activities. The reasons for JACIE and FACT include the complexity of the therapeutic procedure, the production of cell-based medicinal products by academic facilities rather than by pharmaceutical companies.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
